Presentation NY Valves 2025 Bioprosthetic Valve Remodelling: Optimizing Hemodynamics During TAVR in SAVR Presenter: Fabio Sandoli de Brito June 26, 2025
Presentation NY Valves 2025 Featured Research: A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During TAVR Presenter: Robert Gooley June 25, 2025
Presentation NY Valves 2025 Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis Presenter: Samir R. Kapadia June 25, 2025
Presentation NY Valves 2025 Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results Presenter: Hemal Gada June 25, 2025
Presentation NY Valves 2025 National Trends in Aortic Valve Replacement in Patients 65 Years and Younger Presenter: Vikrant Jagadeesan June 25, 2025
Presentation NY Valves 2025 Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors Presenter: Hugo Poinsignon June 25, 2025
Presentation NY Valves 2025 Age Considerations for Aortic Progression with BAV: When Is TAVR Still Acceptable? Presenter: Melissa Levack June 25, 2025
Presentation NY Valves 2025 Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR Presenter: Muhammad Suleman June 25, 2025
Presentation NY Valves 2025 Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials Presenter: Yasser M. Sammour June 25, 2025
Presentation NY Valves 2025 CT Determinants of TAVR Risk: When Should I Treat with TAVR and When Should I Avoid? Presenter: Hasan Jilaihawi June 25, 2025
Presentation NY Valves 2025 Anatomic Considerations for Device Selection: Are Device v Device Trials Meaningful? Presenter: Ole De Backer June 25, 2025
Presentation NY Valves 2025 Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat? Presenter: Matthew John Czarny June 25, 2025
Presentation NY Valves 2025 Is There Hope for Medical Management of Aortic Stenosis? New Potential Therapies for Prevention and Treatment Presenter: Brian R. Lindman June 25, 2025
Presentation NY Valves 2025 Cardiac Damage and Its Impact on Timing of TAVR Presenter: Philippe Genereux June 25, 2025
Presentation NY Valves 2025 SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results Presenter: Pradeep K. Yadav June 25, 2025
Presentation NY Valves 2025 Addressing Undertreatment And Disparities In Valvular Heart Disease: Have We Made Progress? Presenter: Wayne Batchelor June 25, 2025
Presentation NY Valves 2025 Latest Clinical Insights: Bridging Evidence and Practice Presenter: Samir R. Kapadia June 25, 2025
Presentation NY Valves 2025 Optimizing TAVR in Bicuspid Patients with DASI Presenter: Hasan Jilaihawi June 25, 2025
Presentation NY Valves 2025 Efficacy of CEP Devices to Reduce Stroke during TAVR: Insights From the TVT Registry Presenter: David J. Cohen June 25, 2025
Presentation NY Valves 2025 Mitigating Stroke Risk in TAVR: Global Burden and the Role of Embolic Protection Presenter: Suzanne J. Baron June 25, 2025